Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Encaleret in Post-Surgical Hypoparathyroidism
NCT05735015Phase 2Completed
- Sponsor
- National Institute of Dental and Craniofacial Research
- Start
- Sep 2023
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of encaleret in hypoparathyroidism, sponsored by National Institute of Dental and Craniofacial Research. Started Sep 2023; status: completed.
02
Drugs
encaleret
03
Conditions
hypoparathyroidism
Beyond the preview
Go deeper on NCT05735015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05735015.